APA 6th Edition

Debeljak, T. & Kores Plesničar, B. (2021). DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT. Psychiatria Danubina, 33 (suppl 4), 1227-1229. Retrieved from https://hrcak.srce.hr/275511

---

MLA 8th Edition

Debeljak, Tana and Blanka Kores Plesničar. "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT." Psychiatria Danubina, vol. 33, no. suppl 4, 2021, pp. 1227-1229. https://hrcak.srce.hr/275511. Accessed 15 May 2024.

---

Chicago 17th Edition

Debeljak, Tana and Blanka Kores Plesničar. "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT." Psychiatria Danubina 33, no. suppl 4 (2021): 1227-1229. https://hrcak.srce.hr/275511

---

Harvard

Debeljak, T., and Kores Plesničar, B. (2021). 'DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT', Psychiatria Danubina, 33(suppl 4), pp. 1227-1229. Available at: https://hrcak.srce.hr/275511 (Accessed 15 May 2024)

---

Vancouver

Debeljak T, Kores Plesničar B. DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT. Psychiatria Danubina [Internet]. 2021 [cited 2024 May 15];33(suppl 4):1227-1229. Available from: https://hrcak.srce.hr/275511

---

IEEE

T. Debeljak and B. Kores Plesničar, "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT", Psychiatria Danubina, vol.33, no. suppl 4, pp. 1227-1229, 2021. [Online]. Available: https://hrcak.srce.hr/275511. [Accessed: 15 May 2024]